Evidence map›Paper›PMID 37620400›Full record

ArticleNature chemical biology2024

Structural snapshots along K48-linked ubiquitin chain formation by the HECT E3 UBR5.

Laura A Hehl, Daniel Horn-Ghetko, J Rajan Prabu, Ronnald Vollrath, D Tung Vu, David A Pérez Berrocal, Monique P C Mulder, Gerbrand J van der Heden van Noort, Brenda A Schulman

Open access · hybridAbstract read
In one paragraph

Article in Nature chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. MicroRNA-582-5p modulation of UBR5 affects inflammatory response and motor recovery after spinal cord injury.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. E2 variants for probing E3 ubiquitin ligase activities.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Design and Semisynthesis of Ubiquitin Extension Probes.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Internal Ubiquitin Electrophiles for Covalent Trapping and Inhibition of Deubiquitinases.Chembiochem : a European journal of chemical biology · 2025
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Laura A HehlDepartment of Chemistry, School of Natural Sciences, Technical University of Munich, Garching, Germany.
Daniel Horn-GhetkoDepartment of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID 0000-0003-2290-2147
J Rajan PrabuDepartment of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID 0000-0002-7726-9310
Ronnald VollrathDepartment of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried, Germany.
D Tung VuDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID 0000-0002-7573-1591
David A Pérez BerrocalDepartment of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, the Netherlands.
Monique P C MulderDepartment of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, the Netherlands.
Gerbrand J van der Heden van NoortDepartment of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, the Netherlands.
Brenda A SchulmanDepartment of Chemistry, School of Natural Sciences, Technical University of Munich, Garching, Germany. schulman@biochem.mpg.de.
Max Planck Institute of Biochemistry · DELeiden University Medical Center · NL

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) SCHU 3196/1EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 789016-NEDD8Activate
6 · The paper itself

Abstract

Ubiquitin (Ub) chain formation by homologous to E6AP C-terminus (HECT)-family E3 ligases regulates vast biology, yet the structural mechanisms remain unknown. We used chemistry and cryo-electron microscopy (cryo-EM) to visualize stable mimics of the intermediates along K48-linked Ub chain formation by the human E3, UBR5. The structural data reveal a ≈ 620 kDa UBR5 dimer as the functional unit, comprising a scaffold with flexibly tethered Ub-associated (UBA) domains, and elaborately arranged HECT domains. Chains are forged by a UBA domain capturing an acceptor Ub, with its K48 lured into the active site by numerous interactions between the acceptor Ub, manifold UBR5 elements and the donor Ub. The cryo-EM reconstructions allow defining conserved HECT domain conformations catalyzing Ub transfer from E2 to E3 and from E3. Our data show how a full-length E3, ubiquitins to be adjoined, E2 and intermediary products guide a feed-forward HECT domain conformational cycle establishing a highly efficient, broadly targeting, K48-linked Ub chain forging machine.

Indexed as

UbiquitinUbiquitin-Protein LigasesCryoelectron MicroscopyHumansUbiquitinationUbiquitin-Conjugating EnzymesUbiquitinsUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-Protein LigasesUbiquitinsUBR5 protein, human

Identifiers

PMID37620400
PMCPMC10830417
OpenAlexW4386119806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.